Advancing patient care by providing solutions for gastrointestinal disease management.

novoGI is committed to advancing patient care by providing an expanding range of comprehensive solutions for gastrointestinal disease management. The LARATM is the company’s lead product, recently showcased at ASCRS 2012. It is a nitinol-based compression anastomosis device that reconnects the colon after resection. Over 10,000 operations have been performed using novoGI’s clinically proven proprietary technology. With more than 50 peer-reviewed publications the product’s ease of use, healing processes, and successful outcomes in regard to leak rates has been clinically substantiated.

  • CEO Gavriel Meron
  • Industry Medtech
  • History Other